http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111135312-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111135312-B |
| titleOfInvention | Preparation and application of a hybrid nano-preparation based on tumor pan-metabolism regulation |
| abstract | The invention discloses a mixed nano-preparation for promoting tumor blood vessel normalization treatment based on tumor pan-metabolism regulation and application thereof. The mixed nano-preparation is based on the nano-self-assembly technology based on electrostatic interaction and hydrogen bond interaction. Heparin-like polysaccharide macromolecules and their derivatives and active biological macromolecules with VEGF inhibitory activity, or active substances targeting vascular endothelial cells, Nano-drugs targeting tumor cells and tumor vascular endothelial cells are constructed by assembling with non-viral gene carriers and metabolic regulation-related gene drugs with stable properties. The two ternary-assembled nanomedicines formed by physical mixing can achieve significant metabolic regulation of tumor cells and tumor vascular endothelial cells, and promote the normalization of tumor blood vessels. As well as the multiple curative effects of tumor proliferation inhibition, the three synergize, complement each other and enhance each other. |
| priorityDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.